{"id":"https://genegraph.clinicalgenome.org/r/c04d5607-f7f3-4161-b164-234f9e6301cfv1.2","type":"EvidenceStrengthAssertion","dc:description":"ADAR was first reported in relation to type 1 interferonopathy in 2012 when it was found to be associated with Aicardi-Goutieres syndrome (AGS) (Rice et al., PMID: 23001123), a form of type 1 interferonopathy.  Type 1 interferonopathies are defined as conditions in which increased type 1 interferon signaling leads to autoimmune and neurological disorders (MONDO:0700261). ADAR-related type 1 interferonopathies are seen in both the autosomal recessive and autosomal dominant forms. The autosomal dominant forms of ADAR-related type 1 interferonopathy have been curated separately. \n\nThere are 7 missense, 3 frameshift, and 1 nonsense variants that have been reported in 10 probands in 3 publications (PMIDs: 23001123, 24262145, 29221912) included in this curation. More evidence is available in the literature, but the maximum score for genetic evidence (12 pts.) has been reached. The mechanism of pathogenicity appears to be loss of function. This gene-disease relationship is also supported by rescue studies, protein-protein interactions, and animal models (PMIDs: 26275108, 29022589, 34772697). \n\nIn summary, there is definitive evidence supporting the relationship between ADAR and ADAR-related type 1 interferonopathy, including autosomal recessive Aicardi Goutieres syndrome. This has been repeatedly demonstrated in both the research and clinical diagnostic settings, and has been upheld over time. \n\nThe original curation of the association of ADAR with autosomal recessive Aicardi-Goutieres syndrome (AGS) was approved by the ClinGen Brain Malformations GCEP on the meeting date December 12th, 2023 (SOP Version 9). This gene-disease validity curation was transferred to the Leukodystrophy and Leukoencephalopathy GCEP on October 23, 2024, at which time  the disease entity was changed from “autosomal recessive Aicardi Goutieres syndrome” to the more broad disease entity of “autosomal recessive ADAR-related type 1 interferonopathy,” consistent with other genes that are involved in causing type 1 interferonopathies. \n","dc:isVersionOf":"https://genegraph.clinicalgenome.org/r/c04d5607-f7f3-4161-b164-234f9e6301cf","GCISnapshot":"https://genegraph.clinicalgenome.org/r/9cf90ec8-f2fd-4b93-89ca-d20e628a6109","calculatedEvidenceStrength":"Definitive","contributions":[{"id":"https://genegraph.clinicalgenome.org/r/9cf90ec8-f2fd-4b93-89ca-d20e628a6109_publish_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10107","date":"2024-10-31T18:18:07.658Z","role":"Publisher"},{"id":"https://genegraph.clinicalgenome.org/r/9cf90ec8-f2fd-4b93-89ca-d20e628a6109_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10107","date":"2024-10-31T16:00:00.000Z","role":"Approver"}],"curationReasons":["DiseaseNameUpdate"],"evidence":[{"id":"https://genegraph.clinicalgenome.org/r/9cf90ec8-f2fd-4b93-89ca-d20e628a6109_overall_genetic_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/7f8f26ed-70ea-438c-b4eb-37da1c154ea4_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/7f8f26ed-70ea-438c-b4eb-37da1c154ea4","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/23001123","rdfs:label":"Rice_AGS93","ageType":"AgeAtReport","ageUnit":"Years","ageValue":15,"allele":[{"id":"https://genegraph.clinicalgenome.org/r/f8a7cd83-9cb0-4263-9798-a770f1b88331","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001111.5(ADAR):c.2608G>A (p.Ala870Thr)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA343775"}},{"id":"https://genegraph.clinicalgenome.org/r/12a4f790-a00a-43e6-8386-7ee0cf910ff9","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001111.5(ADAR):c.577C>G (p.Pro193Ala)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA345491"}}],"detectionMethod":"Rice et al. used massively parallel sequencing of exomes for probands AGS81_P1 and AGS219 and found variants in ADAR. Then sequenced ADAR in other individuals lacking variants in TREX1, RNASEH2B, RNASEH2C, RNASEH2A and SAMHD1. ","firstTestingMethod":"Other","phenotypes":["obo:HP_0002415","obo:HP_0000737","obo:HP_0011344","obo:HP_0002514","obo:HP_0000007"],"sex":"Male","variant":[{"id":"https://genegraph.clinicalgenome.org/r/86643a22-9a83-49c8-97af-bae0b0ec1188_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/23001123","allele":{"id":"https://genegraph.clinicalgenome.org/r/f8a7cd83-9cb0-4263-9798-a770f1b88331"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}},{"id":"https://genegraph.clinicalgenome.org/r/a21f5a2b-e6a4-41d2-bfad-000a13e64e2e_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/23001123","allele":{"id":"https://genegraph.clinicalgenome.org/r/12a4f790-a00a-43e6-8386-7ee0cf910ff9"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}}]},{"id":"https://genegraph.clinicalgenome.org/r/86643a22-9a83-49c8-97af-bae0b0ec1188","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/86643a22-9a83-49c8-97af-bae0b0ec1188_variant_evidence_item"},{"id":"https://genegraph.clinicalgenome.org/r/86643a22-9a83-49c8-97af-bae0b0ec1188_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Mannion et al. 2014 (PMID: 25456137) found that ADAR p110 and p150 isoform mutants P193A, A870T, R892H, K999N, G1007R, and D1113H expressed in HEK293T cells exhibit a significant decrease in editing activity relative to WT","functionalDataSupport":"Yes"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/a21f5a2b-e6a4-41d2-bfad-000a13e64e2e","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/a21f5a2b-e6a4-41d2-bfad-000a13e64e2e_variant_evidence_item"},{"id":"https://genegraph.clinicalgenome.org/r/a21f5a2b-e6a4-41d2-bfad-000a13e64e2e_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Mannion et al. 2014 (PMID: 25456137) found that ADAR p110 and p150 isoform mutants P193A, A870T, R892H, K999N, G1007R, and D1113H expressed in HEK293T cells exhibit a significant decrease in editing activity relative to WT","functionalDataSupport":"Yes"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":1.0},{"id":"https://genegraph.clinicalgenome.org/r/96fafcaf-0b1d-441f-a999-14d67241299d_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/96fafcaf-0b1d-441f-a999-14d67241299d","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/29221912","rdfs:label":"Schmelzer_Case 1","ageType":"AgeAtReport","ageUnit":"Years","ageValue":14,"allele":[{"id":"https://genegraph.clinicalgenome.org/r/12a4f790-a00a-43e6-8386-7ee0cf910ff9"},{"id":"https://genegraph.clinicalgenome.org/r/a04e2ccd-048b-4dcf-ad20-e9c47845b8eb","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001111.5(ADAR):c.1A>G (p.Met1Val)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA342612306"}}],"detectionMethod":"Panel sequencing using enrichment of coding exons of 4813 genes associated with known clinical phenotypes revealed two heterozygous mutations in ADAR ","firstTestingMethod":"Other","phenotypes":["obo:HP_0001332","obo:HP_0002514","obo:HP_0002376","obo:HP_0001252","obo:HP_0001298","obo:HP_0000007","obo:HP_0001263","obo:HP_0002273"],"sex":"Female","variant":[{"id":"https://genegraph.clinicalgenome.org/r/53a3fc15-474b-4e79-9d83-29a559c5fc82_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/29221912","allele":{"id":"https://genegraph.clinicalgenome.org/r/12a4f790-a00a-43e6-8386-7ee0cf910ff9"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}},{"id":"https://genegraph.clinicalgenome.org/r/6cabdaaf-da1c-45c5-9776-66935a54569d_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/29221912","allele":{"id":"https://genegraph.clinicalgenome.org/r/a04e2ccd-048b-4dcf-ad20-e9c47845b8eb"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}}]},{"id":"https://genegraph.clinicalgenome.org/r/53a3fc15-474b-4e79-9d83-29a559c5fc82","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/53a3fc15-474b-4e79-9d83-29a559c5fc82_variant_evidence_item"},{"id":"https://genegraph.clinicalgenome.org/r/53a3fc15-474b-4e79-9d83-29a559c5fc82_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Mannion et al. 2014 (PMID: 25456137) found that ADAR p110 and p150 isoform mutants P193A, A870T, R892H, K999N, G1007R, and D1113H expressed in HEK293T cells exhibit a significant decrease in editing activity relative to WT","functionalDataSupport":"Yes"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/6cabdaaf-da1c-45c5-9776-66935a54569d","type":"EvidenceLine","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/6cabdaaf-da1c-45c5-9776-66935a54569d_variant_evidence_item"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":0.6},{"id":"https://genegraph.clinicalgenome.org/r/09a38d93-2fea-45e8-aab1-288a42f3babb_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/09a38d93-2fea-45e8-aab1-288a42f3babb","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/24262145","rdfs:label":"Livingston_3","allele":[{"id":"https://genegraph.clinicalgenome.org/r/12a4f790-a00a-43e6-8386-7ee0cf910ff9"},{"id":"https://genegraph.clinicalgenome.org/r/e135ad61-2f07-4e85-895e-02c05c6fa9b2","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001111.5(ADAR):c.1630C>T (p.Arg544Ter)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA10575636"}}],"detectionMethod":"Sanger sequencing of ADAR was performed on patients","firstTestingMethod":"Sanger sequencing","phenotypes":["obo:HP_0002376","obo:HP_0001332","obo:HP_0000007","obo:HP_0002135"],"sex":"Male","variant":[{"id":"https://genegraph.clinicalgenome.org/r/1c59b819-9d31-4ea6-b949-8219a1cc4002_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/24262145","allele":{"id":"https://genegraph.clinicalgenome.org/r/e135ad61-2f07-4e85-895e-02c05c6fa9b2"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}},{"id":"https://genegraph.clinicalgenome.org/r/df6a46c1-b236-4bb3-81a0-340c697118ce_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/24262145","allele":{"id":"https://genegraph.clinicalgenome.org/r/12a4f790-a00a-43e6-8386-7ee0cf910ff9"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}}]},{"id":"https://genegraph.clinicalgenome.org/r/1c59b819-9d31-4ea6-b949-8219a1cc4002","type":"EvidenceLine","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/1c59b819-9d31-4ea6-b949-8219a1cc4002_variant_evidence_item"}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/df6a46c1-b236-4bb3-81a0-340c697118ce","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/df6a46c1-b236-4bb3-81a0-340c697118ce_variant_evidence_item"},{"id":"https://genegraph.clinicalgenome.org/r/df6a46c1-b236-4bb3-81a0-340c697118ce_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Mannion et al. 2014 (PMID: 25456137) found that ADAR p110 and p150 isoform mutants P193A, A870T, R892H, K999N, G1007R, and D1113H expressed in HEK293T cells exhibit a significant decrease in editing activity relative to WT","functionalDataSupport":"Yes"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":2.0},{"id":"https://genegraph.clinicalgenome.org/r/00f48ffd-af73-4172-a92a-edb6ae5ea78a_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/00f48ffd-af73-4172-a92a-edb6ae5ea78a","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/23001123","rdfs:label":"Rice_AGS228","ageType":"AgeAtDeath","ageUnit":"Months","ageValue":10,"allele":{"id":"https://genegraph.clinicalgenome.org/r/d2d3f13b-e005-4232-98f3-894624855656","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001111.5(ADAR):c.3019G>A (p.Gly1007Arg)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA130316"}},"detectionMethod":"Rice et al. used massively parallel sequencing of exomes for probands AGS81_P1 and AGS219 and found variants in ADAR. Then sequenced ADAR in other individuals lacking variants in TREX1, RNASEH2B, RNASEH2C, RNASEH2A and SAMHD1. ","firstTestingMethod":"Other","phenotypes":["obo:HP_0001744","obo:HP_0002415","obo:HP_0002514","obo:HP_0011344","obo:HP_0000007","obo:HP_0001873","obo:HP_0002240","obo:HP_0001511"],"sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/a8623470-ef6f-4208-a337-1071c558fe6b_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/23001123","allele":{"id":"https://genegraph.clinicalgenome.org/r/d2d3f13b-e005-4232-98f3-894624855656"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Homozygous"}}},{"id":"https://genegraph.clinicalgenome.org/r/a8623470-ef6f-4208-a337-1071c558fe6b","type":"EvidenceLine","calculatedScore":1.0,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/a8623470-ef6f-4208-a337-1071c558fe6b_variant_evidence_item"},{"id":"https://genegraph.clinicalgenome.org/r/a8623470-ef6f-4208-a337-1071c558fe6b_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Mannion et al. 2014 (PMID: 25456137) found that ADAR p110 and p150 isoform mutants P193A, A870T, R892H, K999N, G1007R, and D1113H expressed in HEK293T cells exhibit a significant decrease in editing activity relative to WT","functionalDataSupport":"Yes"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":1.0}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":1.0},{"id":"https://genegraph.clinicalgenome.org/r/82af9905-9d2d-4f78-a1f5-5e50941ee88d_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/82af9905-9d2d-4f78-a1f5-5e50941ee88d","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/23001123","rdfs:label":"Rice_AGS251","ageType":"AgeAtReport","ageUnit":"Years","ageValue":8,"allele":[{"id":"https://genegraph.clinicalgenome.org/r/12a4f790-a00a-43e6-8386-7ee0cf910ff9"},{"id":"https://genegraph.clinicalgenome.org/r/6ce0c519-9f29-4e58-b491-039e0c9518d3","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001111.5(ADAR):c.2615T>C (p.Ile872Thr)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA343783"}}],"detectionMethod":"Rice et al. used massively parallel sequencing of exomes for probands AGS81_P1 and AGS219 and found variants in ADAR. Then sequenced ADAR in other individuals lacking variants in TREX1, RNASEH2B, RNASEH2C, RNASEH2A and SAMHD1. ","firstTestingMethod":"Other","phenotypes":["obo:HP_0002514","obo:HP_0002376","obo:HP_0009710","obo:HP_0002415","obo:HP_0000007","obo:HP_0011344"],"sex":"Female","variant":[{"id":"https://genegraph.clinicalgenome.org/r/999d798f-1789-4564-a597-cdf437946acb_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/23001123","allele":{"id":"https://genegraph.clinicalgenome.org/r/12a4f790-a00a-43e6-8386-7ee0cf910ff9"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}},{"id":"https://genegraph.clinicalgenome.org/r/fdfdb9f6-5cb9-4fa1-846e-43f8471c7907_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/23001123","allele":{"id":"https://genegraph.clinicalgenome.org/r/6ce0c519-9f29-4e58-b491-039e0c9518d3"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}}]},{"id":"https://genegraph.clinicalgenome.org/r/fdfdb9f6-5cb9-4fa1-846e-43f8471c7907","type":"EvidenceLine","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/fdfdb9f6-5cb9-4fa1-846e-43f8471c7907_variant_evidence_item"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/999d798f-1789-4564-a597-cdf437946acb","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/999d798f-1789-4564-a597-cdf437946acb_variant_evidence_item"},{"id":"https://genegraph.clinicalgenome.org/r/999d798f-1789-4564-a597-cdf437946acb_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Mannion et al. 2014 (PMID: 25456137) found that ADAR p110 and p150 isoform mutants P193A, A870T, R892H, K999N, G1007R, and D1113H expressed in HEK293T cells exhibit a significant decrease in editing activity relative to WT","functionalDataSupport":"Yes"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":0.6},{"id":"https://genegraph.clinicalgenome.org/r/fb64260f-1165-4ddb-af97-0eb1d66213d5_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/fb64260f-1165-4ddb-af97-0eb1d66213d5","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/23001123","rdfs:label":"Rice_AGS327","ageType":"AgeAtReport","ageUnit":"Years","ageValue":4,"allele":[{"id":"https://genegraph.clinicalgenome.org/r/21f81395-b582-4876-8305-9064a3faba14","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001111.5(ADAR):c.1076_1080del (p.Lys359ArgfsTer14)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA130318"}},{"id":"https://genegraph.clinicalgenome.org/r/12a4f790-a00a-43e6-8386-7ee0cf910ff9"}],"detectionMethod":"Rice et al. used massively parallel sequencing of exomes for probands AGS81_P1 and AGS219 and found variants in ADAR. Then sequenced ADAR in other individuals lacking variants in TREX1, RNASEH2B, RNASEH2C, RNASEH2A and SAMHD1. ","firstTestingMethod":"Other","phenotypes":["obo:HP_0011344","obo:HP_0000737","obo:HP_0002514","obo:HP_0000007","obo:HP_0000252","obo:HP_0011968"],"sex":"Male","variant":[{"id":"https://genegraph.clinicalgenome.org/r/d217a60d-0ee2-4534-99de-cb92a62223ff_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/23001123","allele":{"id":"https://genegraph.clinicalgenome.org/r/12a4f790-a00a-43e6-8386-7ee0cf910ff9"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}},{"id":"https://genegraph.clinicalgenome.org/r/2c6c0f12-406c-42a6-ba15-e40d7a9b4317_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/23001123","allele":{"id":"https://genegraph.clinicalgenome.org/r/21f81395-b582-4876-8305-9064a3faba14"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}}]},{"id":"https://genegraph.clinicalgenome.org/r/d217a60d-0ee2-4534-99de-cb92a62223ff","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/d217a60d-0ee2-4534-99de-cb92a62223ff_variant_evidence_item"},{"id":"https://genegraph.clinicalgenome.org/r/d217a60d-0ee2-4534-99de-cb92a62223ff_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Mannion et al. 2014 (PMID: 25456137) found that ADAR p110 and p150 isoform mutants P193A, A870T, R892H, K999N, G1007R, and D1113H expressed in HEK293T cells exhibit a significant decrease in editing activity relative to WT","functionalDataSupport":"Yes"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/2c6c0f12-406c-42a6-ba15-e40d7a9b4317","type":"EvidenceLine","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/2c6c0f12-406c-42a6-ba15-e40d7a9b4317_variant_evidence_item"}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1.5}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":2.0},{"id":"https://genegraph.clinicalgenome.org/r/08526296-08da-4e1e-ac27-1b51b7b8c971_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/08526296-08da-4e1e-ac27-1b51b7b8c971","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/24262145","rdfs:label":"Livingston_2","allele":[{"id":"https://genegraph.clinicalgenome.org/r/c5ec24f4-8a69-4215-8880-d1c8bfeeabf7","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001111.5(ADAR):c.2515del (p.Thr839ProfsTer6)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA2586963874"}},{"id":"https://genegraph.clinicalgenome.org/r/532fd7c0-2d4f-4cf2-b4f0-bf301dd75bd8","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001111.5(ADAR):c.518A>G (p.Asn173Ser)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA1131690"}}],"detectionMethod":"Sanger sequencing of ADAR was performed on patients","firstTestingMethod":"Sanger sequencing","phenotypes":["obo:HP_0001332","obo:HP_0000007","obo:HP_0011344","obo:HP_0002514"],"sex":"UnknownEthnicity","variant":[{"id":"https://genegraph.clinicalgenome.org/r/355357e4-db9d-419a-baba-3094548b6fbc_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/24262145","allele":{"id":"https://genegraph.clinicalgenome.org/r/532fd7c0-2d4f-4cf2-b4f0-bf301dd75bd8"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}},{"id":"https://genegraph.clinicalgenome.org/r/f83131c6-ed5b-4545-b055-34dd5d17ee5b_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/24262145","allele":{"id":"https://genegraph.clinicalgenome.org/r/c5ec24f4-8a69-4215-8880-d1c8bfeeabf7"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}}]},{"id":"https://genegraph.clinicalgenome.org/r/f83131c6-ed5b-4545-b055-34dd5d17ee5b","type":"EvidenceLine","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/f83131c6-ed5b-4545-b055-34dd5d17ee5b_variant_evidence_item"}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/355357e4-db9d-419a-baba-3094548b6fbc","type":"EvidenceLine","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/355357e4-db9d-419a-baba-3094548b6fbc_variant_evidence_item"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":1.6},{"id":"https://genegraph.clinicalgenome.org/r/4d1963cb-6848-45dc-aa24-3c5399fc6e76_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/4d1963cb-6848-45dc-aa24-3c5399fc6e76","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/23001123","rdfs:label":"Rice_AGS107","ageType":"AgeAtReport","ageUnit":"Years","ageValue":15,"allele":{"id":"https://genegraph.clinicalgenome.org/r/a875013c-d815-4257-aabd-9b68f5d00452","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001111.5(ADAR):c.3337G>C (p.Asp1113His)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA343777"}},"detectionMethod":"Rice et al. used massively parallel sequencing of exomes for probands AGS81_P1 and AGS219 and found variants in ADAR. Then sequenced ADAR in other individuals lacking variants in TREX1, RNASEH2B, RNASEH2C, RNASEH2A and SAMHD1. ","firstTestingMethod":"Other","phenotypes":["obo:HP_0011344","obo:HP_0000252","obo:HP_0002415","obo:HP_0000007","obo:HP_0011968","obo:HP_0002514"],"sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/081aa0f8-2570-4962-b4bf-ac2f6283cf72_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/23001123","allele":{"id":"https://genegraph.clinicalgenome.org/r/a875013c-d815-4257-aabd-9b68f5d00452"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Homozygous"}}},{"id":"https://genegraph.clinicalgenome.org/r/081aa0f8-2570-4962-b4bf-ac2f6283cf72","type":"EvidenceLine","calculatedScore":1.0,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/081aa0f8-2570-4962-b4bf-ac2f6283cf72_variant_evidence_item"},{"id":"https://genegraph.clinicalgenome.org/r/081aa0f8-2570-4962-b4bf-ac2f6283cf72_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Mannion et al. 2014 (PMID: 25456137) found that ADAR p110 and p150 isoform mutants P193A, A870T, R892H, K999N, G1007R, and D1113H expressed in HEK293T cells exhibit a significant decrease in editing activity relative to WT","functionalDataSupport":"Yes"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":1.0}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":1.0},{"id":"https://genegraph.clinicalgenome.org/r/940ff4f6-0c03-4d75-a6ca-06e07807b598_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/940ff4f6-0c03-4d75-a6ca-06e07807b598","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/24262145","rdfs:label":"Livingston_5","allele":[{"id":"https://genegraph.clinicalgenome.org/r/28fae0a1-0bda-4f00-b964-648d52070852","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001111.5(ADAR):c.2565_2568del (p.Asn857AlafsTer17)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA526666269"}},{"id":"https://genegraph.clinicalgenome.org/r/12a4f790-a00a-43e6-8386-7ee0cf910ff9"}],"detectionMethod":"Sanger sequencing of ADAR was performed on patients","firstTestingMethod":"Sanger sequencing","phenotypes":["obo:HP_0002063","obo:HP_0000007","obo:HP_0002376","obo:HP_0002514"],"sex":"UnknownEthnicity","variant":[{"id":"https://genegraph.clinicalgenome.org/r/5637d715-e83e-420c-bc19-db5c78e7bfff_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/24262145","allele":{"id":"https://genegraph.clinicalgenome.org/r/12a4f790-a00a-43e6-8386-7ee0cf910ff9"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}},{"id":"https://genegraph.clinicalgenome.org/r/e316fa2b-e1d7-48f8-9e67-069de7bc454d_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/24262145","allele":{"id":"https://genegraph.clinicalgenome.org/r/28fae0a1-0bda-4f00-b964-648d52070852"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}}]},{"id":"https://genegraph.clinicalgenome.org/r/5637d715-e83e-420c-bc19-db5c78e7bfff","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/5637d715-e83e-420c-bc19-db5c78e7bfff_variant_evidence_item"},{"id":"https://genegraph.clinicalgenome.org/r/5637d715-e83e-420c-bc19-db5c78e7bfff_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Mannion et al. 2014 (PMID: 25456137) found that ADAR p110 and p150 isoform mutants P193A, A870T, R892H, K999N, G1007R, and D1113H expressed in HEK293T cells exhibit a significant decrease in editing activity relative to WT","functionalDataSupport":"Yes"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/e316fa2b-e1d7-48f8-9e67-069de7bc454d","type":"EvidenceLine","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/e316fa2b-e1d7-48f8-9e67-069de7bc454d_variant_evidence_item"}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1.5}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":2.0},{"id":"https://genegraph.clinicalgenome.org/r/e0ac2b6f-02cc-4fc2-b893-95084abdccc4_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/e0ac2b6f-02cc-4fc2-b893-95084abdccc4","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/23001123","rdfs:label":"Rice_AGS81","ageType":"AgeAtReport","ageUnit":"Years","ageValue":14,"allele":[{"id":"https://genegraph.clinicalgenome.org/r/12a4f790-a00a-43e6-8386-7ee0cf910ff9"},{"id":"https://genegraph.clinicalgenome.org/r/381f2a25-99cd-4acd-9954-063a692b7fa2","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001111.5(ADAR):c.2675G>A (p.Arg892His)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA343773"}}],"detectionMethod":"Rice et al. used massively parallel sequencing of exomes for probands AGS81_P1 and AGS219 and found variants in ADAR\n","firstTestingMethod":"Exome sequencing","phenotypes":["obo:HP_0002514","obo:HP_0000252","obo:HP_0000007","obo:HP_0002415","obo:HP_0001332","obo:HP_0011344","obo:HP_0000737"],"sex":"Female","variant":[{"id":"https://genegraph.clinicalgenome.org/r/a328b949-a35e-4c95-a273-b30e6616ca94_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/23001123","allele":{"id":"https://genegraph.clinicalgenome.org/r/12a4f790-a00a-43e6-8386-7ee0cf910ff9"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}},{"id":"https://genegraph.clinicalgenome.org/r/154480d1-6ea3-4d33-9624-93277dc5b2fe_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/23001123","allele":{"id":"https://genegraph.clinicalgenome.org/r/381f2a25-99cd-4acd-9954-063a692b7fa2"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}}]},{"id":"https://genegraph.clinicalgenome.org/r/154480d1-6ea3-4d33-9624-93277dc5b2fe","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/154480d1-6ea3-4d33-9624-93277dc5b2fe_variant_evidence_item"},{"id":"https://genegraph.clinicalgenome.org/r/154480d1-6ea3-4d33-9624-93277dc5b2fe_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Mannion et al. 2014 (PMID: 25456137) found that ADAR p110 and p150 isoform mutants P193A, A870T, R892H, K999N, G1007R, and D1113H expressed in HEK293T cells exhibit a significant decrease in editing activity relative to WT","functionalDataSupport":"Yes"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/a328b949-a35e-4c95-a273-b30e6616ca94","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/a328b949-a35e-4c95-a273-b30e6616ca94_variant_evidence_item"},{"id":"https://genegraph.clinicalgenome.org/r/a328b949-a35e-4c95-a273-b30e6616ca94_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Mannion et al. 2014 (PMID: 25456137) found that ADAR p110 and p150 isoform mutants P193A, A870T, R892H, K999N, G1007R, and D1113H expressed in HEK293T cells exhibit a significant decrease in editing activity relative to WT","functionalDataSupport":"Yes"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":1.0}],"specifiedBy":"GeneValidityOverallGeneticEvidenceCriteria","strengthScore":12},{"id":"https://genegraph.clinicalgenome.org/r/9cf90ec8-f2fd-4b93-89ca-d20e628a6109_experimental_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/9cf90ec8-f2fd-4b93-89ca-d20e628a6109_functional_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/3b413a46-7c3a-4646-a7e7-99cf39673d5c","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/c492765e-3a6a-4e92-8028-0bde68cd117e","type":"Finding","dc:description":"Authors found that AIMP2 interacted with both ADAR1 and ADAR2 via co-immunoprecipitation, and AIMP2 is also implicated in leukodystrophy","dc:source":"https://pubmed.ncbi.nlm.nih.gov/29022589","rdfs:label":"Tan_Protein-Protein Interactions","demonstrates":{"id":"obo:MI_0915"}}],"specifiedBy":"GeneValidityProteinInteractionCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityOverallFunctionalEvidenceCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/9cf90ec8-f2fd-4b93-89ca-d20e628a6109_model_rescue_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/98d2a5b6-6e24-4f48-b57e-ce97bf8b4a1d","type":"EvidenceLine","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/d3ad1c52-bece-4928-a6b0-1158f6bbe68d","type":"Finding","dc:description":"They found that short hairpin RNA (shRNA) knockdown of MDA5 rescued proliferation and viability and suppressed ISG induction in hematopoietic stem and progenitor cells expressing only the Adar1E861A allele to control levels, using two independent MDA5 shRNAs.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/26275108","rdfs:label":"Liddicoat_Rescue","demonstrates":{"id":"cg:PhenotypeRescue"}}],"specifiedBy":"GeneValidityNonHumanRescueCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/fdaae8dc-9e77-4c20-89e1-88ddfb534766","type":"EvidenceLine","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/1c2419de-9f9a-4967-8493-8bb705a5e971","type":"Finding","dc:description":"Like the human phenotype, Adar1K948N/K948N mice displayed postnatal growth delay, hyperplasia of splenic white pulps with germinal centers and hepatic focal inflammation, lung and heart inflammation with lymphocyte infiltration, and white matter abnormalities with astrocytosis and microgliosis.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/34772697","rdfs:label":"Inoue_Mouse Model","demonstrates":{"id":"cg:ProteinAlterationDisruptsOrganismFunction"}}],"specifiedBy":"GeneValidityNonHumanModelOrganismCriteria","strengthScore":2}],"specifiedBy":"GeneValidityOverallModelAndRescueEvidenceCriteria","strengthScore":4}],"specifiedBy":"GeneValidityOverallExperimentalEvidenceCriteria","strengthScore":4.5}],"evidenceStrength":"Definitive","sequence":9281,"specifiedBy":"GeneValidityCriteria11","strengthScore":16.5,"subject":{"id":"https://genegraph.clinicalgenome.org/r/kgub9lFh3LM","type":"GeneValidityProposition","disease":"obo:MONDO_0700261","gene":"hgnc:225","modeOfInheritance":"obo:HP_0000007"},"version":"1.2","websiteLegacyID":"https://genegraph.clinicalgenome.org/r/assertion_9cf90ec8-f2fd-4b93-89ca-d20e628a6109-","@context":{"@vocab":"https://genegraph.clinicalgenome.org/terms/","id":"@id","type":"@type","cg":"https://genegraph.clinicalgenome.org/terms/","dc":"http://purl.org/dc/terms/","obo":"http://purl.obolibrary.org/obo/","hgnc":"https://identifiers.org/hgnc:","rdfs":"http://www.w3.org/2000/01/rdf-schema#","cggv":"https://genegraph.clinicalgenome.org/r/gci/","evidenceStrength":{"@type":"@vocab"},"calculatedEvidenceStrength":{"@type":"@vocab"},"computedEvidenceStrength":{"@type":"@vocab"},"specifiedBy":{"@type":"@vocab"},"evidence":{"@container":"@set"},"disease":{"@type":"@vocab"},"gene":{"@type":"@vocab"},"phenotypes":{"@type":"@id"},"agent":{"@type":"@id"},"role":{"@type":"@vocab"},"modeOfInheritance":{"@type":"@vocab"},"sex":{"@type":"@vocab"},"direction":{"@type":"@vocab"},"ageType":{"@type":"@vocab"},"ageUnit":{"@type":"@vocab"},"dc:source":{"@type":"@id"},"curationReasons":{"@type":"@vocab","@container":"@set"},"GCISnapshot":{"@type":"@id"},"dc:isVersionOf":{"@type":"@id"},"websiteLegacyID":{"@type":"@id"}}}